| ICD-10 Code | Description |
| T44.4X1A | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter |
| T44.4X1D | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
| T44.4X1S | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela |
| T44.4X2A | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter |
| T44.4X2D | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
| T44.4X2S | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela |
| T44.4X3A | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter |
| T44.4X3D | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter |
| T44.4X3S | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela |
| T44.4X4A | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter |
| T44.4X4D | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter |
| T44.4X4S | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela |
| T44.4X5A | Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T44.4X5D | Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
| T44.4X5S | Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela |
| T44.4X6A | Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T44.4X6D | Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
| T44.4X6S | Underdosing of predominantly alpha-adrenoreceptor agonists, sequela |
